Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes

Virology

Volumn 458-459, Issue 1, 2014, Pages 22-32

  Iwasaki, Masaharu ^a   Urata, Shuzo ^a,b   Cho, Yoshitake ^a   Ngo, Nhi ^a   De la Torre, Juan C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Arenavirus; Cell entry; LCMV; Myoblast; Myotube; Skeletal muscle

Indexed keywords

ALPHA DYSTROGLYCAN; CAVEOLIN 3; GLYCOPROTEIN; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 206; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CAV3 GENE; CELL DIFFERENTIATION; CELL SURFACE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; HETEROZYGOTE; INFECTION RESISTANCE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; VIRUS ENTRY; VIRUS INFECTION; VIRUS REPLICATION;

ARENAVIRUS; CELL ENTRY; LCMV; MYOBLAST; MYOTUBE; SKELETAL MUSCLE;

ANIMALS; CAVEOLIN 3; CELL LINE; GENE EXPRESSION REGULATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICRORNAS; MUSCLE FIBERS, SKELETAL; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84899849678     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.013     Document Type: Article

References (81)

1. Accinni L., Archetti I., Branca M., Hsu K.C., Andres G. Tubulo-interstitial (TI) renal disease associated with chronic lymphocytic choriomeningitis viral infection in mice. Clin. Immunol. Immunopathol. 1978, 11:395-405.
2. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
3. Barnes D., Kunitomi M., Vignuzzi M., Saksela K., Andino R. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 2008, 4:239-248.
4. Barresi R., Campbell K.P. Dystroglycan: from biosynthesis to pathogenesis of human disease. J. Cell Sci. 2006, 119:199-207.
5. Battegay M. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates. Altex 1993, 10:6-14.
6. Blau H.M., Chiu C.P., Webster C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 1983, 32:1171-1180.
7. Blau H.M., Webster C. Isolation and characterization of human muscle cells. Proc. Natl. Acad. Sci. USA 1981, 78:5623-5627.
8. Borrow P., Martinez-Sobrido L., de la Torre J.C. Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2010, 2:2443-2480.
9. Borrow P., Oldstone M.B. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology 1994, 198:1-9.
10. Bowe M.A., Deyst K.A., Leszyk J.D., Fallon J.R. Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron 1994, 12:1173-1180.
11. Bray M. Pathogenesis of viral hemorrhagic fever. Curr. Opin. Immunol. 2005, 17:399-403.
12. Brenman J.E., Chao D.S., Xia H., Aldape K., Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995, 82:743-752.
13. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006, 12:1301-1309.
14. Buchmeier M.J., Peters C.J., de la Torre J.C. Arenaviridae: the viruses and their replication. Field[U+05F3]s Virology 2007, 1791-1851. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Holey (Eds.).
15. Bukowski J.F., Biron C.A., Welsh R.M. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J. Immunol. 1983, 131:991-996.
16. Burattini S., Ferri P., Battistelli M., Curci R., Luchetti F., Falcieri E. C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. Eur. J. Histochem.: EJH 2004, 48:223-233.
17. Campanelli J.T., Roberds S.L., Campbell K.P., Scheller R.H. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 1994, 77:663-674.
18. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., Nichol S.T., Compans R.W., Campbell K.P., Oldstone M.B. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 1998, 282:2079-2081.
19. Cardasis C.A., Cooper G.W. An analysis of nuclear numbers in individual muscle fibers during differentiation and growth: a satellite cell-muscle fiber growth unit. J. Exp. Zool. 1975, 191:347-358.
20. Castilla V., Mersich S.E., Candurra N.A., Damonte E.B. The entry of Junin virus into Vero cells. Arch. Virol. 1994, 136:363-374.
21. Cawood R., Chen H.H., Carroll F., Bazan-Peregrino M., van Rooijen N., Seymour L.W. Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog. 2009, 5:e1000440.
22. Charge S.B., Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84:209-238.
23. Doyle M.V., Oldstone M.B. Interactions between viruses and lymphocytes. I. in vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections. J. Immunol. 1978, 121:1262-1269.
24. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991, 66:1121-1131.
25. Fazakerley J.K., Southern P., Bloom F., Buchmeier M.J. High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence. J. Gen. Virol. 1991, 72(Pt 7):1611-1625.
26. Gaster M., Kristensen S.R., Beck-Nielsen H., Schroder H.D. A cellular model system of differentiated human myotubes. APMIS: Acta Pathol., Microbiol., Immunol. Scand. 2001, 109:735-744.
27. Gee S.H., Montanaro F., Lindenbaum M.H., Carbonetto S. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 1994, 77:675-686.
28. Geisbert T.W., Jahrling P.B. Exotic emerging viral diseases: progress and challenges. Nat. Med. 2004, 10:S110-S121.
29. Grady R.M., Grange R.W., Lau K.S., Maimone M.M., Nichol M.C., Stull J.T., Sanes J.R. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat. Cell Biol. 1999, 1:215-220.
30. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., Mirazimi A., Weber F. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PloS One 2008, 3:e2032.
31. Han R., Kanagawa M., Yoshida-Moriguchi T., Rader E.P., Ng R.A., Michele D.E., Muirhead D.E., Kunz S., Moore S.A., Iannaccone S.T., Miyake K., McNeil P.L., Mayer U., Oldstone M.B., Faulkner J.A., Campbell K.P. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc. Natl. Acad. Sci. USA 2009, 106:12573-12579.
32. Hara Y., Kanagawa M., Kunz S., Yoshida-Moriguchi T., Satz J.S., Kobayashi Y.M., Zhu Z., Burden S.J., Oldstone M.B., Campbell K.P. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc. Natl. Acad. Sci. USA 2011, 108:17426-17431.
33. Harker J.A., Lewis G.M., Mack L., Zuniga E.I. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 2011, 334:825-829.
34. Henry R.R., Abrams L., Nikoulina S., Ciaraldi T.P. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 1995, 44:936-946.
35. Hotchin J.E., Cinits M. Lymphocytic choriomeningitis infection of mice as a model for the study of latent virus infection. Can. J. Microbiol. 1958, 4:149-163.
36. Ibraghimov-Beskrovnaya O., Milatovich A., Ozcelik T., Yang B., Koepnick K., Francke U., Campbell K.P. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum. Mol. Genet. 1993, 2:1651-1657.
37. Iwasaki M., Ngo N., de la Torre J.C. Sodium hydrogen exchangers contribute to arenavirus cell entry. J. Virol 2014, 88:643-654.
38. Jung D., Yang B., Meyer J., Chamberlain J.S., Campbell K.P. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J. Biol. Chem. 1995, 270:27305-27310.
39. Kelly E.J., Hadac E.M., Cullen B.R., Russell S.J. MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference. PLoS Pathog. 2010, 6:e1000820.
40. Kelly E.J., Hadac E.M., Greiner S., Russell S.J. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 2008, 14:1278-1283.
41. King C.C., Jamieson B.D., Reddy K., Bali N., Concepcion R.J., Ahmed R. Viral infection of the thymus. J. Virol. 1992, 66:3155-3160.
42. Klavinskis L.S., Oldstone M.B. Lymphocytic choriomeningitis virus can persistently infect thyroid epithelial cells and perturb thyroid hormone production. J. Gen. Virol. 1987, 68(Pt 7):1867-1873.
43. Knapp J.R., Davie J.K., Myer A., Meadows E., Olson E.N., Klein W.H. Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size. Development 2006, 133:601-610.
44. Kogo H., Ito S.Y., Moritoki Y., Kurahashi H., Fujimoto T. Differential expression of caveolin-3 in mouse smooth muscle cells in vivo. Cell Tissue Res. 2006, 324:291-300.
45. Kumar H., Kawai T., Kato H., Sato S., Takahashi K., Coban C., Yamamoto M., Uematsu S., Ishii K.J., Takeuchi O., Akira S. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 2006, 203:1795-1803.
46. Kunz S., Rojek J.M., Kanagawa M., Spiropoulou C.F., Barresi R., Campbell K.P., Oldstone M.B. Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J. Virol. 2005, 79:14282-14296.
47. Kunz S., Rojek J.M., Roberts A.J., McGavern D.B., Oldstone M.B., de la Torre J.C. Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus. J. Virol. 2006, 80:9082-9092.
48. Luo W., Nie Q., Zhang X. MicroRNAs involved in skeletal muscle differentiation. J. Genet. Genomics 2013, 40:107-116.
49. Ma Y.J., Yang J., Fan X.L., Zhao H.B., Hu W., Li Z.P., Yu G.C., Ding X.R., Wang J.Z., Bo X.C., Zheng X.F., Zhou Z., Wang S.Q. Cellular microRNA let-7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells. J. Cell. Mol. Med. 2012, 16:2539-2546.
50. Marq J.B., Hausmann S., Veillard N., Kolakofsky D., Garcin D. Short double-stranded RNAs with an overhanging 5' ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. J. Biol. Chem. 2011, 286:6108-6116.
51. Marq J.B., Kolakofsky D., Garcin D. Unpaired 5' ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I. J. Biol. Chem. 2010, 285:18208-18216.
52. Martinez M.G., Cordo S.M., Candurra N.A. Characterization of Junin arenavirus cell entry. J. Gen. Virol. 2007, 88:1776-1784.
53. Martinez-Sobrido L., Emonet S., Giannakas P., Cubitt B., Garcia-Sastre A., de la Torre J.C. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 2009, 83:11330-11340.
54. Martinez-Sobrido L., Giannakas P., Cubitt B., Garcia-Sastre A., de la Torre J.C. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 2007, 81:12696-12703.
55. Martinez-Sobrido L., Zuniga E.I., Rosario D., Garcia-Sastre A., de la Torre J.C. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 2006, 80:9192-9199.
56. Nathanson N., Monjan A.A., Panitch H.S., Johnson E.D., Petursson G., Cole G.A. Virus-induced cell-mediated immunopathological disease. Viral Immunology and Immunopathology 1975, 357-362. Academic Press, New York. A.L. Notkins (Ed.).
57. Oldstone M.B. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Arenaviruses 2002, 83-118. M.B. Oldstone (Ed.).
58. Pinschewer D.D., Perez M., Sanchez A.B., de la Torre J.C. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc. Natl. Acad. Sci. USA 2003, 100:7895-7900.
59. Pircher H., Burki K., Lang R., Hengartner H., Zinkernagel R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989, 342:559-561.
60. Popescu M., Lohler J., Lehmann-Grube F. Infectious lymphocytes in lymphocytic choriomeningitis virus carrier mice. J. Gen. Virol. 1979, 42:481-492.
61. Quirin K., Eschli B., Scheu I., Poort L., Kartenbeck J., Helenius A. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology 2008, 378:21-33.
62. Rodrigo W.W., de la Torre J.C., Martinez-Sobrido L. Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J. Virol. 2011, 85:1684-1695.
63. Rodriguez M., Garrett R.S., Raitt M., Lampert P.W., Oldstone M.B. Virus persists in beta cells of islets of Langerhans and infection is associated with chemical manifestations of diabetes. II. Morphologic observations. Am. J. Pathol. 1985, 121:497-504.
64. Rojek J.M., Perez M., Kunz S. Cellular entry of lymphocytic choriomeningitis virus. J. Virol. 2008, 82:1505-1517.
65. Rojek J.M., Sanchez A.B., Nguyen N.T., de la Torre J.C., Kunz S. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J. Virol. 2008, 82:7677-7687.
66. Seale P., Asakura A., Rudnicki M.A. The potential of muscle stem cells. Dev. Cell 2001, 1:333-342.
67. Shah W.A., Peng H., Carbonetto S. Role of non-raft cholesterol in lymphocytic choriomeningitis virus infection via alpha-dystroglycan. J. Gen. Virol. 2006, 87:673-678.
68. Song L., Liu H., Gao S., Jiang W., Huang W. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J. Virol. 2010, 84:8849-8860.
69. Sugiyama J., Bowen D.C., Hall Z.W. Dystroglycan binds nerve and muscle agrin. Neuron 1994, 13:103-115.
70. Tsutsumi Y.M., Horikawa Y.T., Jennings M.M., Kidd M.W., Niesman I.R., Yokoyama U., Head B.P., Hagiwara Y., Ishikawa Y., Miyanohara A., Patel P.M., Insel P.A., Patel H.H., Roth D.M. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation 2008, 118:1979-1988.
71. van Rooij E., Liu N., Olson E.N. MicroRNAs flex their muscles. Trends Genet.: TIG 2008, 24:159-166.
72. Vela E.M., Zhang L., Colpitts T.M., Davey R.A., Aronson J.F. Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology 2007, 369:1-11.
73. Weber F., Haller O. Viral suppression of the interferon system. Biochimie 2007, 89:836-842.
74. Wozniak A.C., Kong J., Bock E., Pilipowicz O., Anderson J.E. Signaling satellite-cell activation in skeletal muscle: markers, models, stretch, and potential alternate pathways. Muscle Nerve 2005, 31:283-300.
75. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
76. Yi J.S., Du M., Zajac A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009, 324:1572-1576.
77. Ylosmaki E., Hakkarainen T., Hemminki A., Visakorpi T., Andino R., Saksela K. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J. Virol. 2008, 82:11009-11015.
78. Yoshida M., Hama H., Ishikawa-Sakurai M., Imamura M., Mizuno Y., Araishi K., Wakabayashi-Takai E., Noguchi S., Sasaoka T., Ozawa E. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum. Mol. Genet. 2000, 9:1033-1040.
79. Yoshida N., Yoshida S., Koishi K., Masuda K., Nabeshima Y. Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J. Cell Sci. 1998, 111(Pt 6):769-779.
80. Zammit P.S., Partridge T.A., Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem.: Off. J. Histochem. Soc. 2006, 54:1177-1191.
81. Zinkernagel R.M. Lymphocytic choriomeningitis virus and immunology. Curr. Top. Microbiol. Immunol. 2002, 263:1-5.